BD Vaginal Panel is eligible for reimbursement.

BD is committed to supporting physician offices, hospitals and laboratories that utilize the BD Vaginal Panel. That’s why we provide the following resources and services to help our customers navigate coverage and reimbursement challenges.

BD MAX™ Vaginal Panel Reimbursement and Market Access Toolkit

BD Vaginal Panel Reimbursement and Market Access Toolkit

This toolkit serves as a guide on coding and the appeals process.

Reimbursement Support Services

BD Vaginal Panel Reimbursement Support Services

We provide physicians’ offices, hospitals, and laboratories with a reimbursement hotline and personalized appeals assistance. To get in touch:
Program phone: 1.860.733.0952
Program fax: 1.860.801.8954

Letter of Medical Necessity Template for the BD MAX™ Vaginal Panel

Letter of Medical Necessity Template for the BD Vaginal Panel

This template may be helpful when drafting insurance correspondence for your patients based on their unique medical history (instructions featured in the toolkit).

CodeMap® Website

CodeMap® Website

Visit the reimbursement site dedicated to the BD MAX™ products, hosted and supported by CodeMap®.

Visit website
Current Procedural Terminology (CPT®) that may be applicable to the BD MAX™ Vaginal Panel include: 
CPT Code Description Medicare National Average
81514 Infectious disease, bacterial vaginosis and vaginitis, quantitative real-time amplification of DNA markers for Gardnerella vaginalis, Atopobium vaginae, Megasphaera type 1, Bacterial Vaginosis Associated Baceria-2 (BVAB-2), and Lactobacillus species (L. crispatus and L. jensenii), utilizing vaginal-fluid specimens, algorithm reported as a positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and/or Candida species (C. albicans, C.tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata, Candida krusei, when reported. $262.99

*Disclaimer: Health economic and reimbursement information provided by BD is gathered from third-party sources and is subject to change without notice. The information contained in this reference is presented for information purposes only and does not constitute reimbursement or legal advice. It is always the provider’s responsibility to determine medical necessity and to submit appropriate codes and changes for services that are rendered. BD recommends that you consult with your payers, reimbursement specialist and/or legal counsel regarding coverage, coding, and payment matters. CPT five-digit codes, description, two-digit modifiers and other data are copyright © 2021 American Medical Association. All rights reserved. The codes referenced here are not all-inclusive and are not intended to represent all coding options.

Reminder: Vaginal panels made by other manufacturers test for bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and Trichomonas vaginalis (TV). Only those panels that test for a specific combination of markers, such as BD Vaginal Panel, may be eligible for reimbursement when billed with CPT® Code 81514.

View this vaginitis tests comparator for more detailed information on the available FDA-cleared tests.